Pure Global

IVD Department quantitative d-dimer test - Vietnam Registration 2403389ĐKLH/BYT-HTTB

Access comprehensive regulatory information for IVD Department quantitative d-dimer test in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403389ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403389ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403389ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department quantitative d-dimer test
VN: Bộ IVD xét nghiệm định lượng d‑dimer
Risk Class TTBYT Loại C

Registration Details

2403389ĐKLH/BYT-HTTB

17004105/ĐKLH-BYT-TB-CT

Theo theo phụ lục

Theo phụ lục

Company Information

Technical Details

Roche CARDIAC D-Dimer: RocheCARDIACD‑Dimer is an in vitro diagnostic quantitative immunodetection test designed to determine d-dimer in heparinized venous blood, to be used with the cobash232 instrument. The RocheCARDIACD‑Dimer test is used to support the diagnosis of patients suspected of having deep vein thrombosis and pulmonary embolism. A negative d-dimer test result can exclude these conditions with high probability. The RocheCARDIACD‑Dimer test is performed near the patient. It is not intended for self-testing. Roche CARDIAC Control D-Dimer: RocheCARDIACControlD‑Dimer is used in conjunction with the RocheCARDIAC D‑Dimer test to perform quality control on the cobash232 instrument. RocheCARDIACControlD‑Dimer is performed near the patient. It is not intended for self-testing.

Dates and Status

Nov 06, 2024